Pneumococcal disease can be divided into invasive disease, ie when bacteria are detected
in normally sterile body fluids, and noninvasive disease. Pneumococcal disease occurs …

To overview the present global burden of pneumococcal disease is important because new
preventive measures such as the pneumococcal conjugate vaccine 13 are currently being …

Introduction Streptococcus pneumoniae is a major cause of morbidity and mortality. We
sought to describe the epidemiology of non-invasive and invasive pneumococcal disease in …

Pneumococcal vaccine is effective in preventing invasive pneumococcal disease in adults≥
65 years of age, but it is not widely used in Western Europe. In this study, data from an …

Pneumococcal pneumonia (PP) and invasive pneumococcal disease (IPD) are important
causes of morbidity and mortality in seniors worldwide. Incidence rates and serious …

Background: Pneumococcal pneumonia is a disease of the extremes of age. However, as
other traditional risk factors for pneumococcal pneumonia also increase with older age, it is …

The effective prevention of Streptococcus pneumoniae infection has a renewed priority in an
era in which the emergence of antibacterial-resistant strains has the potential to further …

Clin Microbiol Infect 2012; 18 (Suppl. 5): 7–14 Abstract Streptococcus pneumoniae causes
different types of acute, invasive and non‐invasive clinical infections, being the most …

Introduction Elderly people and adults with chronic disease or compromised immune status
are at increased risk of pneumococcal infection, with pneumonia being the most common …

Background Incidence, manifestations and case-fatality rate (CFR) of invasive
pneumococcal disease (IPD) vary with age and comorbidities. New vaccines, changing age …